The results showing that WHSC1 overexpression stimulated MHC-I expression and sensitized the tumor cells to anti–PD-1 mAb treatment raise the prospect that augmenting WHSC1 activity might enhance antitumor immunity. The gene discussed is NSD2; the disease is neoplasm.